These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21632881)

  • 1. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
    Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
    Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of mindin exacerbates cardiac hypertrophy and fibrosis.
    Bian ZY; Wei X; Deng S; Tang QZ; Feng J; Zhang Y; Liu C; Jiang DS; Yan L; Zhang LF; Chen M; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
    J Mol Med (Berl); 2012 Aug; 90(8):895-910. PubMed ID: 22367478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
    Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
    J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.
    Huang H; Tang QZ; Wang AB; Chen M; Yan L; Liu C; Jiang H; Yang Q; Bian ZY; Bai X; Zhu LH; Wang L; Li H
    Hypertension; 2010 Aug; 56(2):232-9. PubMed ID: 20585109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
    Chen Y; He T; Zhang Z; Zhang J
    Pharmacology; 2021; 106(11-12):667-681. PubMed ID: 34518478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higenamine attenuates cardiac fibroblast abstract and fibrosis via inhibition of TGF-β1/Smad signaling.
    Zhu JX; Ling W; Xue C; Zhou Z; Zhang YS; Yan C; Wu MP
    Eur J Pharmacol; 2021 Jun; 900():174013. PubMed ID: 33766620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.
    Dai J; Shen DF; Bian ZY; Zhou H; Gan HW; Zong J; Deng W; Yuan Y; Li F; Wu QQ; Gao L; Zhang R; Ma ZG; Li HL; Tang QZ
    PLoS One; 2013; 8(1):e53412. PubMed ID: 23349709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells.
    Magaye RR; Savira F; Hua Y; Xiong X; Huang L; Reid C; Flynn BL; Kaye D; Liew D; Wang BH
    Int J Biochem Cell Biol; 2021 May; 134():105952. PubMed ID: 33609744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
    Zhang Y; Shao L; Ma A; Guan G; Wang J; Wang Y; Tian G
    Hypertens Res; 2014 Jan; 37(1):43-9. PubMed ID: 24089264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
    Gu J; Qiu M; Lu Y; Ji Y; Qian Z; Sun W
    Phytomedicine; 2021 Feb; 82():153461. PubMed ID: 33497927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
    Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
    Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.
    Koitabashi N; Danner T; Zaiman AL; Pinto YM; Rowell J; Mankowski J; Zhang D; Nakamura T; Takimoto E; Kass DA
    J Clin Invest; 2011 Jun; 121(6):2301-12. PubMed ID: 21537080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
    Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
    Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.